Sutton Wealth Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sutton Wealth Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-240	Closed	-$38.2K	–	1179
2022 Q4	$38.2K	Hold	240	–	–	0.01%	470
2022 Q3	$32K	Buy	240 +3	+1%	+$456	0.01%	506
2022 Q2	$37K	Hold	237	–	–	0.01%	463
2022 Q1	$36.9K	Hold	237	–	–	0.01%	500
2021 Q4	$30.2K	Buy	237 +7	+3%	+$920	0.01%	576
2021 Q3	$29.9K	Hold	230	–	–	0.01%	560
2021 Q2	$40.9K	Hold	230	–	–	0.01%	466
2021 Q1	$37.8K	Hold	230	–	–	0.01%	470
2020 Q4	$38K	Hold	230	–	–	0.02%	432
2020 Q3	$32.8K	Hold	230	–	–	0.02%	410
2020 Q2	$25.4K	Hold	230	–	–	0.01%	467
2020 Q1	$22.9K	Hold	230	–	–	0.01%	440
2019 Q4	$34.3K	Hold	230	–	–	0.02%	419
2019 Q3	$29.5K	Hold	230	–	–	0.02%	456
2019 Q2	$32.8K	Hold	230	–	–	0.02%	425
2019 Q1	$32.9K	Hold	230	–	–	0.02%	410
2018 Q4	$28.5K	Hold	230	–	–	0.02%	415
2018 Q3	$38.7K	Hold	230	–	–	0.03%	349
2018 Q2	$39.6K	Hold	230	–	–	0.03%	350
2018 Q1	$34.7K	Hold	230	–	–	0.02%	376
2017 Q4	$31K	Hold	230	–	–	0.02%	403
2017 Q3	$33.6K	Hold	230	–	–	0.03%	373
2017 Q2	$35.8K	Hold	230	–	–	0.03%	333
2017 Q1	$33.4K	Hold	230	–	–	0.03%	351
2016 Q4	$25.1K	Hold	230	–	–	0.02%	425
2016 Q3	$27.9K	Sell	230 -3	-1%	-$404	0.03%	375
2016 Q2	$32.9K	Hold	233	–	–	0.03%	314
2016 Q1	$30.4K	Buy	+233	New	+$29K	0.03%	332

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Sutton Wealth Advisors's JAZZ Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2023, closing a stake of 240 shares — an estimated $38.2K sold.

Sutton Wealth Advisors first reported a position in JAZZ in Q1 2016 and held it in 28 quarters. The position peaked at $40.9K in Q2 2021. 471 funds tracked by Wall St. Rank hold JAZZ as of Q1 2023.

Sutton Wealth Advisors reported no remaining Jazz Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Sutton Wealth Advisors sold 240 Jazz Pharmaceuticals shares in Q1 2023, an estimated $38.2K.
Sutton Wealth Advisors first reported a position in Jazz Pharmaceuticals in Q1 2016 and held it in 28 quarters.
Sutton Wealth Advisors's Jazz Pharmaceuticals position peaked at $40.9K in Q2 2021.
471 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.